FDA Clearance Tracker · P150035-S003
Aveir DR Leadless System
Last checked: Nov 20, 2026Latest source record: Jun 29, 2023 (this decision)Source: openFDAMethods & limitations
Decided
Jun 29, 2023
Approved
Time to decision
163 days
Received Jan 17, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P150035-S003
- Device name
- Aveir DR Leadless System
- Applicant
- ABBOTT MEDICAL
- Applicant location
- Sylmar, CA
- Received
- Jan 17, 2023
- Decided
- Jun 29, 2023
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P150035
Device type
- Device type
- Leadless pacemaker (PNJ)
- Device class
- Class III
- Regulation
- 21 CFR 870.3610
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for the Aveir DR Leadless System, Aveir Leadless Pacemaker (Right Ventricular), Aveir Leadless Pacemaker (Right Atrial), Aveir Delivery Catheter, Aveir Link Module.
Source documents
Other decisions for ABBOTT MEDICAL
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P260019 · Decided Oct 27, 2026 · 180 days after receipt
Device type: Para-device leak occluder (SJT) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.